Nikolai Petrovsky is a professor of Medicine at Flinders University and chairman and research director of Vaxine Pty Ltd, an Adelaide-based biotechnology company focused on vaccine development. He has won multiple grants for vaccine adjuvant development from the U.S. National Institutes of Health and has authored over 200 peer-reviewed research papers. He has won many prestigious awards including an Ernst and Young Entrepreneur of the Year Award in 2010 and Asian Executive of the Year award in 2011. His current focus is development of a protein-based vaccine against COVID-19.